| ￥3300 | |
| Z06431-100 | |
|
|
|
|
|
|
|
|
|
| Species | Rat | ||||
| Protein Construction |
|
||||
| Purity |
> 95% as determined by BisTris PAGE > 95% as determined by HPLC |
||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 44.67 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 50-65 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
The purity of Serpina3n, His, Rat is greater than 95% as determined by SEC-HPLC. »
Serpina3n, His, Rat on Bis-Tris PAGE under reduced condition. The purity is greater than 95% »
| Target Background | Serpina3n is a secretory serine protease inhibitor belonging to clade "a" exhibiting unique structural and physiological characteristics, playing significant roles ranging from complement cascade, apoptosis, wound healing to Alzheimer by inhibiting a wide range of proteases. |
| Synonyms | Serpin A3N; CPI-26; CPI26; SPI-2.2; SPI2.2; SPI-3; SPI3; Spin2c; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
